Skip to main content
Clinical Trials/NL-OMON55649
NL-OMON55649
Completed
Not Applicable

INDICO AF - Atrial Fibrillation in patients with an implantable cardioverter defibrillator and coronary artery disease. - INDICO AF

Academisch Medisch Centrum0 sites50 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Academisch Medisch Centrum
Enrollment
50
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational non invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Age between 18 and 80 years
  • CAD, evident from a) previous myocardial infarction or b) revascularization
  • through PCI or CABG
  • LVEF\<35%, quantified on MRI, with nuclear imaging or determined by
  • echocardiography
  • Willing and able to sign informed consent and to comply with the protocol and
  • with the follow\-up
  • Life expectancy \> 2 years

Exclusion Criteria

  • Unwilling to sign informed consent
  • Current atrial fibrillation
  • A history of atrial fibrillation not including postoperative atrial
  • fibrillation
  • Previous catheter or surgical ablation for atrial fibrillation
  • Current use or current indication of vitamin K antagonist or NOACs
  • Use of class 1 or 3 antiarrhythmic drugs for ventricular or supraventricular
  • arrhythmia \` other than AF
  • Prosthetic heart valves
  • Dilated or hypertrophic cardiomyopathy

Outcomes

Primary Outcomes

Not specified

Similar Trials